Pedalitin is primarily used in the pharmaceutical industry as an intermediate in the synthesis of anti-inflammatory and analgesic agents. It exhibits inhibitory activity against certain cyclooxygenase (COX) enzymes, contributing to its role in reducing prostaglandin production, which is associated with pain and inflammation. Due to its structural properties, it is also investigated for potential use in developing treatments for neurodegenerative conditions, where modulation of oxidative stress and inflammation is beneficial. In research settings, Pedalitin serves as a reference compound for structure-activity relationship (SAR) studies aimed at optimizing drug candidates with improved bioavailability and reduced side effects.